Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma

被引:0
作者
C. Festuccia
A. Mancini
A. Colapietro
G. L. Gravina
F. Vitale
F. Marampon
S. Delle Monache
S. Pompili
L. Cristiano
A. Vetuschi
V. Tombolini
Y. Chen
T. Mehrling
机构
[1] University of L’Aquila,Laboratory of Radiobiology, Department of Applied Clinical Sciences and Biotechnologies
[2] University of L’Aquila,Laboratory of Radiobiology, Department of Applied Clinical Sciences and Biotechnologies
[3] University of L’Aquila,Division of Radiotherapy, Department of Applied Clinical Sciences and Biotechnologies
[4] University of L’Aquila,Division of Neurosciences, Department of Applied Clinical Sciences and Biotechnologies
[5] University of L’Aquila,Division of Applied Biology, Department of Applied Clinical Sciences and Biotechnologies
[6] University of L’Aquila,Division of Human Anatomy, Department of Applied Clinical Sciences and Biotechnologies
[7] University of L’Aquila,Laboratory of Applied Biology, Department of Life, Health and Environmental Sciences
[8] University of Rome “La Sapienza”,Division of Radiotherapy, Department of Experimental Medicine
[9] Northlake International LLC,undefined
[10] Mundipharma-EDO GmbH,undefined
来源
Journal of Hematology & Oncology | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 1 条
  • [1] Festuccia C(2018)The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma J Hematol Oncol 11 32-undefined